Grants and contracts awarded to Yale School of Medicine

July/August, 2010


Federal

  • David J. Adle, NIH, Functional Characterization of an ER-Resident Ligase in Yeast, 3 years, $150,234 
  • Serap Aksoy, NIH, Evidence-Based Control Strategies of Sleeping Sickness Vectors, 3 years, $176,780 
  • Allen E. Bale, NIH, Genetic Epidemiology of Early-Onset Basal Cell Carcinoma, 2 years, $165,500 
  • Michael H. Bloch, NIH, Longitudinal Structural MRIStudy of Adulthood Outcome in Tourette Syndrome, 5 years, $902,154 
  • Titus Boggon, NIH, Regulation of Polycystin-2 Channel Activity, 4 years, $1,730,781
  • Angelique Bordey, U.S. Army Medical Research Acquisition Activity (Department of Defense), Understanding the Etiology of Tuberous Sclerosis Complex, 3 years, $730,792
  • Richard Bucala, NIH, Defining Signatures for Immune Responsiveness by Functional Systems Immunology, 1 year, $53,738
  • William B. Cafferty, NIH, Plasticity of Intact Circuits Restores Function after Spinal Cord Injury, 3 years, $747,000
  • Michael J. Caplan, Department of Defense, A New Therapeutic Strategy for Autosomal Dominant Polycystic Kidney Disease: Activation of AMPKinase by Metformin, 3 years, $1,241,250
  • Sreeganga S. Chandra, NIH, The Physiological Functions of Synucleins, 1 year, $1,851,531
  • Marek C. Chawarski, NIH, Behavioral Drug and HIVRisk Reduction Counseling with MMTin China, 5 years, $3,123,146
  • Yung-Chi Cheng, NIH, Biochemical Pharmacology of Anti-HIVCompounds, 5 years, $2,068,750
  • Tian H. Chi, NIH, Epigenetic CD4 Regulation Stability and Epimutations, 11 months, $413,275
  • Elizabeth B. Claus, NIH, The Meningioma Consortium: Genome-Wide Association Study, 3 years, $3,828,168
  • Joseph E. Craft, NIH, Immune Response in Lupus, 5 years, $2,146,502
  • Michael C. Crair, NIH, Neurobiology of Cortical Systems, 5 years, $1,002,485
  • Charles S. Dela Cruz, NIH, Molecular and Cellular Interaction Between Cigarette Smoke Exposure and RSVin the Lung, 5 years, $669,600
  • Richard L. Edelson, NIH, Dermatology Training Grant, 5 years, $1,629,774
  • Tore Eid, NIH, Glutamine Synthetase and the Mechanism of Seizures in Mesial Temporal Lobe Epilepsy, 5 years, $1,810,155
  • Stephanie C. Eisenbarth, NIH, Role of the NLRP3 Inflammasome in Adaptive Immunity, 5 years, $667,575 
  • Jack A. Elias, NIH, Training in Respiratory Biology and Pathobiology, 5 years, $2,908,390
  • Veraragavan P. Eswarakumar, NIH, Mechanisms of FGRFR2 Signaling in Salivary Gland Branching Morphogenesis, 5 years, $2,056,899
  • Erol Fikrig, NIH, Defining Signatures for Immune Responsiveness by Functional Systems Immunology, 1 year, $210,864 
  • Harald G. Foellmer, NIH, Development of a Flavivirus E Protein Fusion Loop Vaccine, 2 years, $165,500 
  • Brian W. Forsyth, NIH, Development of an International Guide to Monitor and Support Child Development, 5 years, $2,583,807
  • Jorge E. Galán, NIH, Molecular Genetic Analysis of SalmonellaCell Invasion, 5 years, $2,602,374
  • Mark B. Gerstein, Department of Energy, Tools and Models for Integrating Multiple Cellular Networks, 2 years, $1,170,951
  • Michael Girardi, NIH, Local Immunoregulation of Carcinogenesis, 5 years, $1,809,151
  • Abha R. Gupta, NIH, Identification of Candidate Genes at the Synapse in Autism Spectrum Disorders, 4 years, $681,027
  • David Hafler, NIH, Defining Signatures for Immune Responsiveness by Functional Systems Immunology, 1 year, $2,430,086; NIH,Costimulatory Mechanisms of Autoimmunity, 5 years, $8,540,473; NIH,Costimulatory Mechanisms of Autoimmunity, 1 year, $2,859,450
  • Isaac E. Hall, NIH, Urinary Biomarkers for Recovery After Acute Kidney Injury and Prognosis in Hospitalized Patients, 1 year, $65,841
  • Mark W. Hochstrasser, NIH, Predoctoral Program in Cellular and Molecular Biology, 5 years, $11,541,618
  • Dewan Syed Fahmeed Hyder, NIH, Multivalent PARACESTAgents for Quantitative Molecular Imaging, 4 years, $1,347,079; NIH, Translation of Smart Contrast Agents for Brain Tumor Characterization by MR, 5 years, $1,613,701
  • Karl L. Insogna, NIH, Impact of a Protein Supplement on Bone Mass in Older Women, 1 year, $424,412; NIH, Role of CSF-1 in Osteoclast Function, 1 year, $413,750
  • Shuta Ishibe, NIH, Role of Focal Adhesion Kinase (Fak) in Nephrosis and Nephritis, 5 years, $2,068,750
  • James D. Jamieson, NIH, Medical Student Training Program, 5 years, $10,965,240
  • Susan Kaech, NIH, Defining Signatures for Immune Responsiveness by Functional Systems Immunology, 1 year, $210,200
  • Insoo Kang, Department of the Army, Studying the Role for CD4+ T Cell Subsets in Human Lupus, 3 years, $1,241,250; Department of Defense,Studying the Role for CD4+ T Cell Subsets in Human Lupus, 3 years, $3,723,750
  • Barbara I. Kazmierczak, NIH, Innate Immune Responses to Type III Secretion System Components and Effectors, 4 years, $1,799,161
  • Tae Hoon Kim, NIH, Analysis of Higher Order Chromatin Structures in Normal and Cancer Epigenomes, 5 years, $1,717,065
  • Steven H. Kleinstein, NIH, Defining Signatures for Immune Responsiveness by Functional Systems Immunology, 1 year, $241,804
  • Albert I. Ko, NIH, Disease Determinants of Urban Leptospirosis, 5 years, $3,472,193; NIH, Natural History of Urban Leptospirosis, 4 years, $1,221,739
  • Diane S. Krause, NIH, MKLin Megakaryocytopoiesis, 4 years, $1,443,989
  • James F. Leckman, NIH, Training Program in Childhood Neuropsychiatric Disorders, 5 years, $2,274,453
  • Csaba Leranth, NIH, Bisphenol A Effect on Primate Brain, 2 years, $1,413,822
  • Ethan P. Marin, NIH, The Role of Protein Palmitoylation in Endothelial Cell Function, 5 years, $673,650
  • Graeme F. Mason, NIH, Ethanol as Fuel for the Brain in Rats, 2 years, $439,405
  • Carolyn Mazure, NIH, Yale BIRCWHScholar Program on Women’s Health and Addictive Behaviors, 5 years, $2,476,819
  • Sherry McKee, NIH, Does Tobacco Legislation Reduce Alcohol Consumption? 2 years, $512,190
  • Ruth R. Montgomery, NIH, Defining Signatures for Immune Responsiveness by Functional Systems Immunology, 1 year, $596,225
  • Christopher Moore, Agency for Healthcare Research and Quality/DHHS, Identifying Unnecessary Irradiation of Patients with Suspected Renal Colic, 4 years, $1,973,901
  • Michael H. Nathanson, NIH, Ca2+ Waves in Hepatocytes: Mechanisms and Effects, 5 years, $2,396,796
  • Ingrid M. Nembhard, Agency for Healthcare Research and Quality/DHHS, Understanding the Implementation of New Practice in Health Care Organizations, 10 months, $488,402
  • James Noonan, NIH, Identifying Enhancers with Human-Specific Developmental Functions, 5 years, $3,352,861
  • Marcella Nunez-Smith, NIH, Measuring Racial/Ethnic Discrimination/Bias on Health Care Delivery, 2 years, $395,959
  • Kevin Pelphrey, NIH, A fNIRSSystem to Further Research on Neurodevelopmental Disorders, 1 year, $444,700
  • Francheska Perepletchikova, Nat’l Inst. of Mental Health and Neuro Sciences (India), Adapting Dialectical Behavior Therapy for Children with Suicidality and/or Self-Harm Behaviors: Pilot Randomized Clinical Trial with Maltreated Children in Foster Care, 1 year, $180,074
  • Ismene L. Petrakis, NIH, Translational Neuroscience Research in Alcoholism, 5 years, $1,072,316
  • Christopher Pittenger, NIH, Pathophysiologically Realistic Mouse Models of Neuropsychiatric Disease: Tourette Syndrome, 5 years, $2,214,743
  • Katerina Politi, NIH, Mechanisms of Mutant Epidermal Growth Factor Receptor–Induced Lung Tumorigenesis, 3 years, $810,141
  • Lori A. Post, Agency for Healthcare Research and Quality/DHHS, ED Disability Diagnostic Tool: A HITFeasibility Study, 5 years, $2,485,754
  • Marc N. Potenza, NIH, Translational Research of Cocaine, Striatum, and Impulsivities, 4 years, $3,834,967
  • Vincent J. Quagliarello, NIH, Program of Research in Infectious Diseases of Elders, 5 years, $671,625
  • Yibing Qyang, NIH, Derivation and Functional Characterization of Heart Cells from Human Embryonic and Induced Pluripotent Stem Cells, 5 years, $504,930
  • David L. Rimm, NIH, Predicting Metastasis in Melanoma, 4 years, $1,505,671
  • Jesse J. Rinehart, NIH, Investigation of Electrolyte Homeostasis via Quantitative Proteomics, 5 years, $771,560
  • Scott A. Rivkees, Food and Drug Administration, Radioactive Iodide Therapy of Pediatric Graves’ Disease, 4 years, $1,600,000
  • Joseph S. Ross, NIH, Impact of Publicly Reporting Hospital Outcomes Measures for Older Adults, 3 years, $442,710
  • Douglas L. Rothman, NIH, 13C MRSStudies of Human Brain Mitochondrial Metabolism in Healthy Aging, 4 years, $2,052,625
  • James E. Rothman, NIH, Mechanisms of Intracellular Membrane Fusion, 5 years, $3,646,441
  • Jonathan Saxe, NIH, Investigating the Role of a Novel PIWI-Interacting Protein in Spermatogenesis, 2 years, $105,508
  • Richard S. Schottenfeld, NIH, INVESTDrug Abuse Research Fellowship, 1 year, $39,000
  • William C. Sessa, NIH, Regulation of Vascular Remodeling and Angiogenesis by Nogo, 5 years, $2,566,184
  • Albert C. Shaw, NIH, Defining Signatures for Immune Responsiveness by Functional Systems Immunology, 1 year, $713,174
  • Haina Shin, NIH, Antigen-Specific CD8 T Cell Migration and Protective Immunity in Permissive and Restrictive Tissues, 3 years, $143,670
  • Satinder K. Singh, NIH, Transport and Inhibition in a Biogenic Amine Transporter, 3 years, $741,325
  • David L. Snow, NIH, Research Training Program in Substance Abuse Prevention, 5 years, $1,542,175
  • Daniel J. Spergel, NIH, Calcium Signaling in the Pubertal Activation of the GnRH Pulse Generator, 15 months, $17,928
  • Thomas A. Steitz, NIH, Structures of DNAand RNAPolymerases and Functional Complexes, 4 years, $1,871,229
  • Hanna E. Stevens, NIH, Prenatal Stress and the Development of Inhibitory Neurons in the Forebrain, 5 years, $870,435
  • Stephen M. Strittmatter, NIH, Prion Protein in Alzheimer’s Disease Pathophysiology, 5 years, $1,696,375
  • Nancy E. Suchman, NIH, Fostering Mothers’ Emotionally Responsive Parenting, 5 years, $2,108,700
  • Patrick Sung, NIH, DNARepair Genes and Proteins of the RAD52 Group, 5 years, $2,124,273
  • Joann B. Sweasy, NIH, DNAPolymerase Beta Variants in Cancer, 5 years, $2,021,612
  • Hemant D. Tagare, NIH, Fast 3D Reconstruction Algorithms for Cryo-EM,4 years, $1,666,512
  • Elisabetta Ullu, NIH, RNAMetabolism in Trypanosomes, 5 years, $3,953,019
  • Emily Wang, NIH, Improving Cardiovascular Outcomes in Individuals with a History of Incarceration, 5 years, $689,855
  • Sherman M. Weissman, NIH, Transcriptome and Methylome Analysis of Single Cells, 2 years, $455,177
  • Lynn D. Wilson, NIH, Racial Disparities in Clinical Outcomes and the Therapeutic Use of Radiotherapy for Patients with Cutaneous Lymphoma, 1 year, $82,750
  • John J. Wysolmerski, NIH, Function of the Calcium Sensing Receptor in the Breast, 5 years, $1,623,595
  • Andrew Xiao, NIH, A Novel Enzymatic Activity of WSTFand its Role in Tumorigenesis, 3 years, $747,000
  • Kimberly A. Yonkers, NIH, Project START: Screening to Augment Referral to Treatment, 5 years, $3,541,448
  • Herbert Yu, NIH, Epidemiologic Study of Hepatocellular Carcinoma in the U.S., 5 years, $6,987,938
  • Yongli Zhang, NIH, Single-Molecule Manipulation of SNARES, 5 years, $1,551,550
  • Heping Zhang, NIH, Research Training in Mental Health Epidemiology, 5 years, $2,243,687
  • Yong Zhu, NIH, Can Shift-Work Shift Epigenetic Patterns? 2 years, $445,035
  • Lingjun Zuo, NIH, Deep Sequencing of CNR1 Gene Network in Substance Dependence, 5 years, $909,090

Non-Federal

  • Vikki M. Abrahams, American Heart Association, Effect of Antiphospholipid Antibodies on Trophoblast Function and Vascular Remodeling in Pregnant APSPatients, 3 years, $196,405
  • Amy M. Ahasic, Cystic Fibrosis Foundation, Cystic Fibrosis Center, 1 year, $26,980
  • Jeremy Baskin, Jane Coffin Childs Memorial Fund, Investigation of a Protein Complex Implicated in P14P Synthesis in the Brain, 3 years, $143,500
  • Ariel Bazzini, Pew Latin American Fellows Program, Regulation of the Maternal to Zygotic Transition in Zebrafish, 4 years, $65,000
  • Michael H. Bloch, American Academy of Child and Adolescent Psychiatry, Double-Blind, Placebo-Controlled Trial of N-acetylcysteine for Childhood Tourette Syndrome, 2 years, $60,000
  • Daniel J. Boffa, CALGB Foundation, Evaluation of Novel MolecularNSCLCClassification System, 1 year, $33,000
  • Elizabeth H. Bradley, Commonwealth Fund, All-Cause Hospital Readmission Rate for Patients with Heart Failure and Acute Myocardial Infarction: What Hospital Practices Make a Difference and How Are They Adopted? 2 years, $390,850; South Essex Partnership NHS Foundation Trust, SEPTLeadership Workshop, 1 year, $140,000
  • Joseph Brennan, Abbott Laboratories Inc., Cardiovascular Training Fellowship Grant, 1 year, $34,434
  • Ketan R. Bulsara, Stryker Instruments, Skull Base Cerebrovascular Dissection Fund, 1 year, $7,700
  • Jessica A. Cardin, Esther A. & Joseph Klingenstein Fund, Distinct Sources of Inhibition Differentially Regulate Cortical Activity, 1 year, $50,000; Whitehall Foundation, Inc., Role of Inhibition in Visual Gain Modulation and Perception, 3 years, $225,000
  • Tobias Carling, Doris Duke Charitable Foundation, Systematic Analysis of Human Endocrine Tumor Genomes, 3 years, $255,000; Damon Runyon Cancer Research Foundation, Molecular Genetics of Endocrine Tumor Disease, 3 years, $225,000
  • Anees Chagpar, University of Louisville, Louisville Breast Cancer Update,1 year, $7,108
  • Jaehyuk Choi, Dermatology Foundation, Genetic Screen for Tumor Suppressors in Mouse Skin Using PiggyBac Transposon Mutagenesis, 1 year, $30,000
  • Jennifer N. Choi, Dermatology Foundation, Isotretinoin Versus Doxycycline as Preemptive Therapy for EGFRInhibitor–Induced Papulopustular Rash, 1 year, $20,000
  • Chuhan Chung, National Pancreas Foundation, Regulation of Pancreatic Fibrotic Responses by Pigment Epithelium-Derived Factor(PEDF), 1 year, $44,516
  • Gary W. Cline, Medical College of Georgia, Database Mining of Phenotype Induced by High-Fat Diets, 1 year, $3,000
  • Susan R. Compton, ACLAM Foundation, Assessment of Risk of Transmission of Mouse Parvovirus from Immunodeficient C57BL/6 Mice, 1 year, $30,000
  • William E. Damsky, Joanna M. Nicolay Melanoma Foundation, Inc.,Joanna M. Nicolay Melanoma Foundation Award, 1 year, $10,000
  • Kamil Detyniecki, National EpiFellows Foundation, Patient Recognition of Seizures During In-patient Video-EEG Monitoring, 1 year, $19,000
  • Kavita Dhodapkar, Charles A. Dana Foundation, Inc., Targeting Human Glioma Stem Cells via Dendritic Cells, 3 years, $200,000 
  • Xuemei Dong, Arthritis Foundation, The Transcription Factor Mash2 in Follicular Helper T Cell Differentiation, 2 years, $100,000
  • Jamie L. Duke, Phrma Foundation, Computational Modeling of Genome-Wide Targeting of Somatic Hypermutation, 2 years, $33,333
  • Ronald S. Duman, Repligen Corporation, Influence of Uridine on Behavior in the Forced Swim Test, 1 year, $19,569
  • Daniel R. Duncan, Howard Hughes Medical Institute, Elucidating the Role of PDGFin Neovessel Formation, 1 year, $27,000
  • E. Jennifer Edelman, Society of General Internal Medicine, Prescription Opioids and their Impact on Quality of Life, HIVProgression, and CARTAdherence, 1 year, $5,000
  • Paul S. El-Fishawy, American Academy of Child and Adolescent Psychiatry, A Pilot Study of Whole-Exome Sequencing and Homozygosity Mapping in the Identification of Genes that Contribute to Autism, 15 months, $15,000
  • Gerald Friedland, Albert Einstein College of Medicine, Impact of HIV Co-Infection and TB Genotype on Treatment Outcomes in MDR, 1 year, $108,069
  • Anna-Rachel Gallagher, American Heart Association (Founders Affiliate), The Role of Fibrocystin in Wnt signaling and Mechanism of Repair, 3 years, $231,000
  • Mark B. Gerstein, Brigham and Women’s Hospital, Analysis of Patterns of Structural Variation in the 1,000 Genomes Data Set, 21 months, $442,594
  • Daniel R. Goldstein, American Society of Transplantation,Nanoparticles: A Novel Approach to Deliver Tolerogenic Agents in Experimental Transplantation, 1 year, $40,000
  • Jose L. Gomez-Villalobos, Aerocrine Inc. USA, Characterize the Relations Between FENOand Asthma Severity in the YCAADCohort, 1 year, $25,000
  • Christopher H. Gottschalk, Teva Pharmaceuticals USA, Multiple Sclerosis Fellowship-TEVA, 1 year, $50,000
  • Jeffrey Grotzke, Cancer Research Institute, Inc., Membrane Receptors and Associated Signaling Pathways in Cross-Presentation, 3 years, $144,000
  • David Hafler, Brigham and Women’s Hospital, TIMFamily of Genes: Role in T Cell Immunity and Tolerance: Project 2, 3 years, $862,257
  • Marc Hammarlund, Ellison Medical Foundation, Mechanisms of Age-Related Decline in Axon Regeneration, 4 years, $400,000
  • Jonas O. Hannestad, Nancy Taylor Foundation for Chronic Diseases, Inc., Glutamate Receptor Type 5 During Interferon-Alpha Treatment of Hepatitis C, 2 years, $218,040
  • Jorge Henao-Mejia, Leukemia and Lymphoma Society, Role of the MicroRNA-181 Family in Hematopoiesis and Leukemopoiesis, 3 years, $162,100
  • Gretchen Hermes, American Psychiatric Institute for Research and Education, Psychosocial Regulation of Mood Disorders: Translational Models of Depression, 1 year, $2,500
  • Kevan Herold, Juvenile Diabetes Research Foundation International,IL-1RA and Oral Insulin on Reversal of Diabetes in NODMice, 1 year, $88,000
  • Yoko Ibuka, Social Science Research Council, Cost-Effective Strategies of Influenza Vaccination in the U.S. and Japan, 1 year, $55,931
  • Shuta Ishibe, Satellite Healthcare, Inc., The Role of Synaptojanin-1 in Regulation Podocyte Homeostasis, 3 years, $150,000
  • Roger J. Jou, Pfizer Inc., U.S. Pharmaceuticals Group, The Neural Basis of Weak Central Coherence in Autism Spectrum Disorders, 1 year, $32,500
  • Nina Kadan-Lottick, American Cancer Society, Inc., Comparing Two Models of Cancer Survivorship Care: A Randomized Trial, 4 years, $720,000
  • Anil K. Karihaloo, American Heart Association (Founders Affiliate),Understanding the Role of Chemokine Receptor CXCR4 in Kidney Development, 3 years, $198,000
  • Barbara I. Kazmierczak, Mayo Foundation, Evaluating Innate Immune Responses to Staphylococcus aureusAcquisition and Carriage in Cohorts of Persistent Carriers and Non-Carriers, 10 months, $100,000
  • Robert D. Kerns, The Mayday Fund, Implementing a VA Stepped Care Model of Pain Management, 5 years, $400,000; Patrick and Catherine Weldon Donaghue Medical Research Foundation, Implementing a VA Stepped Care Model of Pain Management, 5 years, $400,000
  • Ami Klin, Simons Foundation, Brain-Behavior Growth Charts of Altered Social Engagement in ASDInfants, 3 years, $751,048
  • Felix Knauf, National Kidney Foundation, Molecular Physiology of Urinary Oxalate Excretion, 2 years, $100,000
  • Narae Ko, American Society of Nephrology, Transepithelial Oxalate Transport in the Proximal Tubule of Kidney, 11 months, $25,500
  • Harlan M. Krumholz, Robert Wood Johnson Foundation, The RWJFClinical Scholars Program COREGrant, 2010–2012, 2 years, $1,035,425; Robert Wood Johnson Foundation, The RWJFClinical Scholars Program Cohort Grant, 2010–2012, 2 years, $1,020,995; Robert Wood Johnson Foundation, The RWJFClinical Scholars Program: 3rd year Cohort (2010–2011), 1 year, $98,875
  • David S. Lee, American Society for Clinical Pharmacology and Therapeutics, Development of Risk Prediction Models in Older Adults on Antihypertensive Medications for Cardiovascular and Falls Outcomes, 1 year, $35,000
  • Mathieu Lemaire, Kidney Foundation of Canada, Novel Insights into Proximal Tubule Function: Finding Novel Disease-Causing Genes in a Large Cohort of Patients with Dent’s Disease Without Mutation in CLCN5 or OCRL1 Using Whole-Exome Capture, 3 years, $195,000
  • Chiang-Shan Li, Tourette Syndrome Association, Inc., Cognitive Motor Control in Tourette Syndrome: Subcortical Noradrenergic Processes, 1 year, $75,000
  • Yilun S. Liu, Elsa U. Pardee Foundation, Elucidation of the Molecular Basis of RECQ4 Deficiency in Cancer Pathogenesis, 1 year, $100,000
  • Charles J. Lockwood, Eastern Connecticut Health Network Services, Inc., Eastern Connecticut Health Network, Inc. Oncology Affiliated Hospital Agreement FY10, 5 months, $7,500
  • Nils Loewen, Lumenis Ltd., Selective Laser Trabeculoplasty Repeatability, 15 months, $10,000
  • Xiaomei Ma, Regents of the University of California, Environmental and Molecular Epidemiology of Childhood Leukaemia, 1 year, $5,989
  • John D. MacMicking, Crohn’s and Colitis Foundation of America,Functional Importance of Immunity-Related GTPases in IBDDevelopment, 3 years, $386,100
  • Una Makris, American College of Rheumatology, Epidemiology of Restricting Back Pain in Older Persons, 2 years, $153,000
  • Robert W. Makuch, IMD Marketing Consulting Co., Ltd, Yale University: Food, Drug & Medical Device Administration Training, 6 months, $64,300
  • Jaime G. Maldonado-Aviles, Hilda and Preston Davis Foundation, Role of the Prefrontal Cortex and Related Molecular Mechanisms in Altered Feeding Behaviors, 3 years, $165,000
  • Lisa M. Mattei, American Heart Association (Founders Affiliate), Control of Lymph Node Vascular Growth by CD4 T Cells, 2 years, $44,000
  • James C. McPartland, Simons Foundation, Brain–Behavior Growth Charts of Altered Social Engagement in ASDInfants, 3 years, $245,205
  • Charlotte Mitchell, American Lung Association, Interferon-Gamma Effects on the Airway Epithelium Modulate Lung Disease, 1 year, $65,000
  • Masahiro Murakami, American Heart Association, Mechanisms of Heart Failure Development in Mice Lacking Cardiomyocyte FGFSignaling, 4 years, $308,000
  • Thomas S. Murray, Charles H. Hood Foundation, The Role of Lactate Metabolism in P. aeruginosa Biofilm Formation, 2 years, $150,000
  • Marcella Nunez-Smith, Josiah Macy Jr. Foundation, Promotion and Retention of Diversity in Medical Education (PaRoDime), 2 years, $250,000
  • Haakon B. Nygaard, American Foundation for Aging Research, The Role of Cellular Prion Protein in Beta-Amyloid-Induced Epilepsy and Early Death in Alzheimer’s Disease Mouse Model, 1 year, $50,054
  • Lynda U. Odofin, University of Vermont, Prevalence of Clostidium difficle (C. diff.)in Connecticut Swine Farms, 17 months, $12,520
  • A. David Paltiel, Massachusetts General Hospital, The Cost-Effectiveness of Preventing HIVComplications, 1 year, $20,788
  • Alexander Panda, Brookdale Foundation Group, Dendritic Cell Immunoscenescence: Characterizing TLRFunction of Human Dendritic Cells in the Elderly, 2 years, $175,911
  • Eon Joo Park, American Heart Association (Founders Affiliate), Role of Nogo-B and NgBR in Vascular Function and Cholesterol Homeostasis, 2 years, $83,000
  • In-Hyun Park, Charles H. Hood Foundation, Investigation of Functional Myogenic Progenitors from Reprogrammed IPScells for Duchenne Muscular Dystrophy, 2 years, $150,000
  • Anup Patel, Plastic Surgery Educational Foundation, A Novel Approach to Measuring the Impact of Surgery in Craniosynotosis with ERPS, 1 year, $10,000
  • Rhea Paul, International Society for Autism Research, Slifka/Ritvo Innovation in Autism Research, 1 year, $12,500
  • Kevin Pelphrey, Simons Foundation, Brain–Behavior Growth Charts of Altered Social Engagement in ASDInfants, 3 years, $503,747
  • Jamy Peng, American Cancer Society, Inc., Molecular Mechanism of Gene Regulation by Polycomb Proteins, 14 months, $62,461
  • Marc N. Potenza, University of Maryland, Genetic Contributions to Adolescent HIVRisk Behavior, 5 years, $401,307
  • Peter M. Rabinowitz, Mary Imogene Bassett Hospital, Infection Risk in Swine Workers, 1 year, $14,999
  • Ziba Razinia, American Heart Association, Characterization of the Role of Filamins, Important Regulators of Cardiovascular Development, in Cell Migration, 2 years, $44,000
  • Anamika M. Reed, American Gastroenterological Association, The Role of Pathologic Calcium Signaling in Low pH Effects in the Pancreatic Acinar Cell, 2 years, $80,000
  • Michael Robek, Sunshine Lake Pharma Co., Ltd, Anti-HBVActivity ofGLS4 In Transgenic Mice, 9 months, $99,563
  • Robert M. Rohrbaugh, Gilead Foundation, Gilead Didactic Curriculum and Clinical Elective FY11, 1 year, $200,000
  • Neil D. Romberg, Clinical Immunology Society, Functional Defects and Molecular Compensation in the B Cells of Patients Carrying TAC1Mutations, 1 year, $30,000
  • Joseph S. Ross, American Federation for Aging Research, AFAR, 3 years, $252,183
  • Jennifer P. Ruger, Greenwall Foundation, Ethical Issues in Health Policy, 3 years, $232,073
  • Christian Schlieker, Ellison Medical Foundation, Deciphering the Nuclear Quality Control Network and its Relation to Aging, 4 years, $400,000; Charles H. Hood Foundation, Investigating Nuclear Envelopathies from the Perspective of Protein Quality Control, 2 years, $150,000
  • Amy R. Schwartz, New York University School of Medicine, Tailoring Clinical Guidelines to Comorbidity, 8 months, $57,994
  • Ambika R. Shenoy, Cystic Fibrosis Foundation, CFTRFunction in Macrophages and Neutrophils, 1 year, $68,250
  • Robert S. Sherwin, American Diabetes Association, Inc., CNSResponses to Hypoglycemia in Diabetes, 2 years, $81,000
  • Warren D. Shlomchik, University of Pittsburgh, Peripheral Mechanisms of Immunologic Tolerance, 1 year, $812,961
  • Francesco Strino, American-Italian Cancer Foundation, Development of Complex System Tools for Fingerprinting Subclonal Tumor Composition, 1 year, $35,000
  • Zhaoxia Sun, American Cancer Society, Inc., Functional Connections Between the Tor Pathway and the Cillium in Zebrafish, 4 years, $720,000
  • Grace C. Teng, Cancer Research Institute, Inc., Genome-wide Mapping of RAG1 and RAG2 Protein Binding, 3 years, $141,000
  • Mary E. Tinetti, American Federation for Aging Research, 2010 Competitive National CoE Program Award Application, 1 year, $123,921
  • Robert J. Tomko, American Cancer Society, Inc., American Cancer Society New England Division: Massachusetts Biotechnology Council Cancer Research Challenge, Millennium: The Takeda Oncology Company Postdoctoral Fellowship, 3 years, $150,000
  • Lucy A. Truman, University of Edinburgh, Do Pro-Inflammatory T Cells Home to Tertiary Lymphoid Organs in Sjögren’s Disease and Cultivate Lymphoma? 1 year, $104,130
  • Amelia Villagomez, American Psychiatric Association, APAFellowship, 1 year, $34,470
  • Narendra Wajapeyee, American Association for Cancer Research,Understanding the Mechanisms of BCR-ABL-Mediated Transformation, 2 years, $100,000
  • Jason S. Weinstein, Arthritis Foundation, T Follicular Help Cells in Immunity and Autoimmunity, 2 years, $100,000
  • Sherman M. Weissman, University of Massachusetts, HOXCluster Intergenic Non-Coding RNAs in Myeloid Differentiation and Function, 4 years, $1,765,487
  • Carol C. Weitzman, Lulac Head Start Inc., Lulac Head Start, 1 year, $30,000
  • Marney A. White, American Heart Association, Internet-Administered Smoking Cessation Treatment for Overweight and Obese Smokers, 3 years, $197,659
  • Robert I. White, University of California, San Francisco, Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Disease Clinical Research Network, 1 year, $82,251
  • Yong Xiong, Alex’s Lemonade Stand, Elucidating the Initiation Mechanism of the Fanconi Anemia Pathway of DNADamage Repair, 2 years, $200,000
  • Yang Yang, American Federation for Aging Research, Nicotinic Restoration of Prefrontal Cortex Physiology in Aged Monkeys, 1 year, $45,710
  • James J. Yue, Orthopaedic Research and Education Foundation, Yale Comprehensive Spine Fellowship, 1 year, $69,500